SCHEMBL13601278

SCHEMBL13601278

Nc1nc(-c2ccn[nH]2)c2cnn(Cc3cccc([N+](=O)[O-])c3)c2n1

nearest known ligand 0.67

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 19/20 0.67
ADORA1 P30542 16/20 0.67
ADORA2B P29275 2/20 0.49
ADORA3 P0DMS8 1/20 0.49
PAX8 Q06710 1/20 0.41
HDAC1 Q13547 4/20 0.41
HDAC3 O15379 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601285 0.85 ADORA2A (0.65) ADORA2AADORA1ADORA2BADORA3HDAC1
SCHEMBL13707441 0.83 ADORA2A (0.67) ADORA2AADORA1ADORA2BADORA3
SCHEMBL13601287 0.83 ADORA2A (0.66) ADORA2AADORA1ADORA2BADORA3HDAC1
SCHEMBL4457050 0.81 ADORA2A (0.67) ADORA2AADORA1ADORA2BADORA3PAX8
SCHEMBL13601277 0.81 ADORA2A (0.66) ADORA2AADORA1ADORA2BADORA3PAX8
SCHEMBL4457174 0.81 ADORA2A (0.69) ADORA2AADORA1ADORA2BADORA3HDAC1
SCHEMBL4453233 0.81 ADORA2A (0.66) ADORA2AADORA1ADORA2BADORA3PAX8
SCHEMBL4452866 0.80 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3HDAC1
SCHEMBL13601265 0.77 ADORA2A (0.64) ADORA2AADORA1ADORA2BADORA3HDAC1
SCHEMBL13601273 0.73 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629349-B2 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2009-12-08 US disclosed
US-7629349-B2 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2009-12-08 US disclosed